Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Neurologists who Treat Neuromuscular Disorders (US)

March 19, 2007
Prescriber Data sales, drug pricing, drug marketing
By a GLG Expert Contributor
Analysis of: Hands Off Prescribing Data, Says Vermont (www.pharmexec.com)
This article raises an important issue which is not widely known by the general public or even among physicians.
March 19, 2007
Statins for prostate ca prevention?
By a GLG Expert Contributor
Analysis of: Statin Drugs and Risk Of Advanced Prostate Cancer (www.medicalnewstoday.com)
This article describes an interesting study which may show that commonly prescribed medications (statins) have an added benefit.
March 19, 2007
Vaccine would have a major impact on world health
By a GLG Expert Contributor
Analysis of: Novel tuberculosis vaccine shows promising immunogenicity and safety profile (www.pipelinereview.com)
Article describes a new promising TB vaccine.
December 5, 2006
Reliance on newer antipsychotics for behavior management questioned
By a GLG Expert Contributor
Analysis of: NEWER ANTIPSYCHOTICS FALL SHORT FOR MANY WITH ALZHEIMER'S DEMENTIA, NIMH STUDY FINDS. (www.neurotodayonline.com)
Newer antipsychotics have been relied on for behavioral management in dementia, given presumed beneficial side effect profile.Study refutes this clinical idea.
December 5, 2006
Personalized Medicine
By a GLG Expert Contributor
Analysis of: Personalized Medicine Promises Tailor-Made Diagnoses, Treatment (news.nationalgeographic.com)
Emerging pharmaceutical technology.Prescribing unique treatment specific for each patient.Possibly removing trial and error prescribing with more analytical approach.

Previous Page : 1 2 3 4 5 651 to 55 of 55

Analytics


Generated at 2009-01-07T19:00:58.307